Fig. 8
From: CBX3 promotes clear cell renal carcinoma through PI3K/AKT activation and aberrant immunity
Potential drug sensitivity assessment of CBX3 expression. A Variations in the expression of immune-checkpoint-related genes between CBX3 high- and low-expression groups. B Correlation analysis on expression between immune checkpoints and CBX3. C Correlation analysis of CBX3 expression with activity score of different drugs acquired from the CellMiner database. *p < 0.05, **p < 0.01, ***p < 0.001